4//SEC Filing
Reich Siegfried 4
Accession 0001209191-22-008984
CIK 0001595893other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:10 PM ET
Size
12.1 KB
Accession
0001209191-22-008984
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-02-09$36.30/sh−397$14,411→ 3,448 total - Award
Common Stock
2022-02-09+13,567→ 17,015 total - Award
Stock Option (right to buy)
2022-02-09+48,833→ 48,833 totalExercise: $37.68Exp: 2032-02-08→ Common Stock (48,833 underlying)
Footnotes (3)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- [F2]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- [F3]1/48th of the shares vest monthly following February 9, 2022.
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001351888
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:10 PM ET
- Size
- 12.1 KB